The option for the stake runs until three years after the publication of T-Cell's 2022 audited annual earnings report. The purchase price is set at five times T-Cell's average EBITDA in the previous two business years.

Masterplast already holds a 24% stake in T-CELL.

T-Cell had net sales revenue of HUF 3.2 billion last year, public records show. Operating profit came to HUF 269 million.